Profile
Mikael Hansson has held positions at Unionen and AstraZeneca AB.
He is currently the Director at Unionen and the Principal at AstraZeneca AB.
Mikael Hansson active positions
| Companies | Position | Start |
|---|---|---|
Unionen
 Unionen Miscellaneous Commercial ServicesCommercial Services Unionen operates as a member-driven organization built on representative democracy. It provides trade union membership services including different forms of insurance, such as the income insurance scheme in the event of unemployment and life insurance, as well as loans and study grants. It also offers training courses, seminars, and other activities. The company was founded on January 1, 1971 and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Unionen
Unionen Miscellaneous Commercial ServicesCommercial Services Unionen operates as a member-driven organization built on representative democracy. It provides trade union membership services including different forms of insurance, such as the income insurance scheme in the event of unemployment and life insurance, as well as loans and study grants. It also offers training courses, seminars, and other activities. The company was founded on January 1, 1971 and is headquartered in Stockholm, Sweden. | Commercial Services |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Mikael Hansson
